|
|
|
市場調查報告書
心血管介入市場
Interventional Cardiology
|
心血管介入市場 是由出版商Global Industry Analysts, Inc.在2010年06月所出版的。
這份英文市場調查報告書包含Pages: 492 價格從美金4450起跳。
本報告書內容包括:全球的心血管介入市場的分析、市場的趨勢和課題、競爭環境、心血管介入的優點和風險、主要企業的介紹、各國市場分類趨勢的彙整、內容綱要摘記如下:
第1章 介紹・調查方法・產品定義
第2章 實施摘要
- 全球市場展望
- 心血管介入：介紹
- 市場預測
- 市場概要
- 技術展望
- 冠動脈支架
- 市場趨勢和課題
- 高齡化促進冠動脈支架市場
- 新一代支架
- 血管成形用氣球導管取代傳統的繞道術手術
- 心血管介入處理件數著實的成長
- 技術開發促進成長 其他
- 競爭環境
- 國際的心臟學概要
- 心臟學
- 心血管介入
- 心血管介入的理想
- 心血管介入的優點
- 心血管介入的風險
- 心血管介入所適合的心血管患者
- 心血管介入處置
- 心血管介入設備
- 產品認定
- 產品上市
- 最近的業界活動
- 主要企業
- Abbott Laboratories
- Abbott Vascular
- AGA Medical Holdings, Inc.
- B. Braun Melsungen AG
- Biosensors International Group Ltd.
- Boston Scientific Corp.
- Cardiac Dimensions, Inc.
- COOK Medical, Inc.
- Cordis Corp.
- Edwards Lifesciences Corp
- Eurocor GmbH
- ev3, Inc.
- Goodman Co.,LTD.
- Medtronic, Inc.
- Medtronic Vascular, Inc.
- Merit Medical Systems, Inc.
- NMT Medical
- Spectranetics Corp.
- St. Jude Medical, Inc.
- TERUMO CORPORATION
- Thermocore Medical Limited
- Translumina GmbH
- Vascular Solutions, Inc.
- Volcano Corp.
- 全球市場展望
第3章 市場
第4章 競合情勢
Abstract
This report analyzes the worldwide markets for Interventional Cardiology in
US$ Million. The market for Interventional Cardiology Devices is analyzed by
the following product segments: Coronary Stents, Peripheral Devices,
Angioplasty Catheters, Intravascular Ultrasound, Vascular Sealings/ Vascular
Closure Devices, and Others. The report provides separate comprehensive
analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual
estimates and forecasts are provided for each region for the period 2006
through 2015. The report profiles 73 companies including many key and niche
players such as Abbott Laboratories, Abbott Vascular, AGA Medical Holdings,
Inc., B. Braun Melsungen AG, Biosensors International Group Ltd., Boston
Scientific Corporation, Cardiac Dimensions, Inc., COOK Medical, Inc., Cordis
Corporation, Edwards Lifesciences Corp., Eurocor GmbH, ev3, Inc., Goodman
Co., Ltd., Medtronic, Inc., Medtronic Vascular, Inc., Merit Medical Systems,
Inc., NMT Medical, Spectranetics Corporation, St. Jude Medical, Inc., Terumo
Corporation, Terumo Medical Corporation, Thermocore Medical Limited,
Translumina GmbH, Vascular Solutions, Inc., and Volcano Corporation. Market
data and analytics are derived from primary and secondary research. Company
profiles are mostly extracted from URL research and reported select online
sources.
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- Coronary Stents
- Peripheral Devices
- Angioplasty Catheters
- Intravascular Ultrasound
- Vascular Sealings/ Vascular Closure Devices
- Others
II. EXECUTIVE SUMMARY
1. GLOBAL MARKET REVIEW
- Table 1: Global Coronary Heart Disease Prevalence by Region (includes
corresponding Graph/Chart)
- Interventional Cardiology: An Introduction
- Coronary Artery Disease - The Leading Cause for Interventional Cardiology
Procedures
- Table 2: Deaths Due to Major Cardiovascular Diseases in the US:
Percentage Share Breakdown by Disease Type (includes corresponding
Graph/Chart)
- Market Estimates and Forecasts
- Geographic Market Performance
- Product Segment Review
- Market Overview
- Interventional Cardiology Technology Prospects
- Coronary Stents - The Leading Interventional Cardiology Device Segment
- Table 3: World Coronary Stents Market (2006-2011): Percentage Breakdown
of Value Sales by Stent Type for Bare-Metal Stents and Drug-eluting Stents
(includes corresponding Graph/Chart)
- Table 4: World Bare Metal Stents Market (2007-2010): Percentage
Breakdown of Value Sales by Geographic Region - US, Japan, Europe,
Asia-Pacific and Rest of World (includes corresponding Graph/Chart)
- Drug-Eluting Stents - The Best-Selling Coronary Stents
- Table 5: World Drug-Eluting Stents Market (2007-2010): Percentage
Breakdown of Value Sales by Geographic Region - US, Japan, Europe,
Asia-Pacific and Rest of World (includes corresponding Graph/Chart)
- Drug-Eluting Stents Market Bounces Back
- Cypher And Taxus Dominate Global DES Market
- Drug Eluting Stent System - Safety Concerns
- Bare Metal Coronary Stents
- IVUS Devices - The Fastest Growing Segment
- Vascular Sealings - A Fast Growing IC Segment
- Future Prospects Of Vascular Sealings
- Embolic Protection Devices - Improving PCI Outcomes In SVG Procedures
- DES Opportunities For Smaller Players
2. MARKET TRENDS & ISSUES
- Aging Population Propels Coronary Stent Market
- Table 6: Aging Population in the US by Age Group for Years 1990-2030
(includes corresponding Graph/Chart)
- Next Generation Stents - A Boon for Treating Coronary Diseases
- Balloon Angioplasty Wins Edge Over Conventional Bypass Surgery
- Interventional Cardiology Procedural Volume Recording Steady Growth
- Technological Advancements to Drive Growth
- Lack of Pharmacological Alternatives Boost Demand for Cardiovascular
Catheters
- Molding Material and Technology Advancements
- Diagnostic Catheters - Advance from the Workhorse 8 Fr.
- Smaller Shafts and Colors - The New in Catheters
- Coronary Stents Market Challenged by Drug Therapy
- PTCA Catheters - Affected by Direct Stenting
- Angioplasty - Under Price Pressure
- Restenosis - The Unsolved Problem
- Cell Transplantation - A Major Threat to Coronary Stents
- Repeat Interventional Procedures Affected by the Advent of Drug-Eluting
Stents
- Energy-Based Solutions Compete with Conventional Interventional Systems
- New Pharmacological Therapies Minimizing the Need for Interventional
Procedures
3. COMPETITIVE LANDSCAPE
- The BIG Four
- Major Interventional Cardiology Device Players
- Coronary Stents - Leading Players
- Table 7: World Coronary Stents Market by Leading Players (2009-2011):
Market Share Breakdown for Boston Scientific, Abbott/Guidant, Johnson &
Johnson , Medtronic, and Others (includes corresponding Graph/Chart)
- Bare Metal Stents - Leading Players
- Table 8: World Bare Metal Stents Market (2009-2011): Percentage
Breakdown of Revenues by Leading Players - Abbott/Guidant, Medtronic, Boston
Scientific, Johnson & Johnson and Others (includes corresponding
Graph/Chart)
- Drug-Eluting Stents - Leading Players
- Table 9: World Drug Eluting Stents Market (2009-2011): Market Share
Breakdown by Leading Players - Boston Scientific, Abbott/Guidant, Johnson
& Johnson, Medtronic and Others (includes corresponding Graph/Chart)
4. OVERVIEW OF INTERVENTIONAL CARDIOLOGY
- Cardiology
- Interventional Cardiology
- The Ideal Candidate for Interventional Cardiology
- Interventional Cardiology Benefits
- Interventional Cardiology Risks
- Certain Cardiovascular Diseases for Interventional Cardiology
- Coronary Artery Disease
- Peripheral Arterial Disease
- Heart Valve Disease
- Interventional Cardiology Procedures
- Cardiac Catheterization
- Coronary Angioplasty
- Table 10: World Angioplasty and Stent Procedures in Millions (2007-2011)
(includes corresponding Graph/Chart)
- Valvuloplasty
- Percutaneous Valve Replacement
- Coronary Thrombectomy
- Cardiac Ablation
- Atherectomy
- Interventional Cardiology Devices
- Coronary Stents
- Bare Metal Stents
- Select Leading Bare-Metal Stents by Company
- Drug Eluting Stents
- Select Leading Drug-Eluting Stents by Company
- Drugs for Coating DESs
- Select Leading Coronary Stent Brands
- Cypher
- Structure and Delivery Mechanism
- Taxus
- Structure and Delivery Mechanism
- Catheters
- Angiography Catheters
- PTCA Catheters
- Types of Balloon Catheters
- Rapid -Exchange PTCA Balloon Catheter
- Over-The-Wire PTCA Balloon Catheter
- Peripheral Devices
- Intravascular Ultrasound
- Vascular Sealings/ Vascular Closure Devices
- Embolic Protection Devices
- Others
- Atherectomy Catheters
- Guide Catheters
- Guidewires
5. PRODUCT APPROVALS
- Conditional IDE Approval for ORBIT II Clinical Trial with Diamondback
360® System
- US FTC Approves Getinge and Datascope Merger
- Xtent Obtains CE Mark for Custom NX Drug-Eluting Stent System
- Invatec Obtains CE Mark for IN.PACT Falcon Paclitaxel-Eluting PTCA Balloon
Catheter
- Medtronic Obtains Approval for Endeavor in Japan
- Atrium Medical Gains EU Approval for Cinatra™
- Boston Scientific Obtains FDA Approval for TAXUS® Liberte®
- Boston Scientific Obtains FDA Approval for Taxus® Express2™
- Health Canada Approves Abbott' s XIENCE V®
- Angiotech Receives CE Certification for Zilver® PTX® Stent
- NMT Medical Obtains PMA Approval from US FDA for STARFlex® Implant
- Cordis Receives FDA Approval for a Smaller Version of CYPHER® Stent
- Boston Scientific Receives CE Mark for PROMUS® ElementTM
- Biosensors International Obtains CE Mark for Small- Diameter BioMatrix
Stent
- AGA Medical Receives CE Mark for AMPLATZER® Cardiac Plug
- AGA Medical Gains CE Mark Approval for AMPLATZER® Vascular Plug III
- AGA Medical Gets CE Mark for AMPLATZER® Duct Occluder II
- Cook Medical Receives FDA Clearance for Balloon Dilatation Catheter
- Cardiac Dimensions® Receives CE Mark for Carillontm Mitral Contour
Systemtm
- Medtronic Receives the US FDA Approval to Use Endeavor® Stent
- Boston Scientific to Market TAXUS® Liberte® Stent System in Canada
- Global Therapeutics Receives CE Mark for Global Therapeutics GTX Coronary
Stent System
- OrbusNeich Obtains CE Mark
- Abbott' s 2.25mm-Sized XIENCE™ V Drug Eluting Stent receives CE Mark of
Approval
- Cook Medical Gains CE Mark Approval for MiraFlexTM High Flow Microcatheter
- Terumo Receives CE Certification for NoboriTM DEC Stent System
- Abbott Applies for Approval of XIENCE™ V in Japan
- Tryton Medical' s Side-Branch Stent Achieves CE Mark Approval
- MIV Therapeutics Obtains DCGI Approval
- Cook Medical' s Zilver Stent Receives Approval for Vascular Use In Canada
6. PRODUCT LAUNCHES
- Boston Scientific Introduces iCross Coronary Imaging Catheter
- Boston Scientific Launches TAXUS® Liberte® DES System in Japan
- Abbott Introduces VOYAGER™ NC Coronary Balloon Catheter
- Invatec Introduces Coronary Drug-Eluting Balloon Platform IN.PACT
- Terumo Launches Glidewire AdvantageTM Peripheral Guidewire
- Invatec Launches REEF HPTM PTA Balloon Catheter
- Tryton Medical Launches Side-Branch Stent
- Terumo Interventional Systems Introduces Coronary Diagnostic Catheters
- Medtronic Launches Endeavor Sprint Drug Eluting Stent
- Medtronic to Introduce Balloon Catheters and Coronary Stents
- Cordis Introduces SAVVY® and SLEEK™ Balloon Catheters
- Volcano Launches Integrated FFR and Rotational IVUS
- Medtronic Launches Defender Embolic Protection Filter
- Biosensors Introduces BioMatrix® Drug-Eluting Stent
- St. Jude Medical Unveils Refllexion Spiral XTM Catheter
- Volcano Launches PrimeWire™ Pressure Guidewire and s5-FFR Option for
Existing Fleet of s5 IVUS Consoles
7. RECENT INDUSTRY ACTIVITY
- Medtronic to Acquire Invatec
- Lake Region Medical Acquires Brivant Medical
- Abbott Acquires Evalve
- Texcel and Circle Medical Announce Merger
- Volcano and Lumen Biomedical Enter into Distribution Agreement
- Volcano Enters into Alliance with Siemens Healthcare
- Spectranetics Acquires Embolic Protection Products from Kensey Nash
- MEDRAD Merges With Possis Medical
- St. Jude Medical to Acquire RadiMedical
- St. Jude Medical Acquires EP MedSystems
- Volcano Takes Over Novelis
- Heraeus Vadnais Takes Over Synovis Life Technologies
- Novation Signs Deal with Medtronic for Endeavor Zotarolimus DES
- Boston Scientific Enter into Agreement with Trivitron
- Volcano and Royal Philips Electronics Sign North America Resale Agreement
- MMDIA Receives Patent Allowance for BetaWire™ Guidewire
- Cordis to Market ClearStream Technologies' Catheters
- Abbott Laboratories Acquires Nova Science
8. FOCUS ON SELECT PLAYERS
- Abbott Laboratories (US)
- Abbott Vascular (US)
- AGA Medical Holdings, Inc. (US)
- B. Braun Melsungen AG (Germany)
- Biosensors International Group Ltd. (Singapore)
- Boston Scientific Corp. (US)
- Cardiac Dimensions, Inc. (US)
- COOK Medical, Inc. (US)
- Cordis Corp. (US)
- Edwards Lifesciences Corp. (US)
- Eurocor GmbH (Germany)
- ev3, Inc. (US)
- Goodman Co., Ltd. (Japan)
- Medtronic, Inc. (US)
- Medtronic Vascular, Inc. (US)
- Merit Medical Systems, Inc. (US)
- NMT Medical (US)
- Spectranetics Corp. (US)
- St. Jude Medical, Inc. (US)
- Terumo Corp. (Japan)
- Terumo Medical Corporation (Japan)
- Thermocore Medical Limited (UK)
- Translumina GmbH (Germany)
- Vascular Solutions, Inc. (US)
- Volcano Corp. (US)
9. GLOBAL MARKET PERSPECTIVE
- Table 11: World Recent Past, Current & Future Analysis for
Interventional Cardiology Devices by Geographic Region - US, Japan, Europe,
Asia-Pacific (Excl. Japan) and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart)
- Table 12: World 10-Year Perspective for Interventional Cardiology Devices
by Geographic Region - Percentage Breakdown of Dollar Sales for US, Japan,
Europe, Asia-Pacific (Excl. Japan) and Rest of World Markets for Years 2006,
2009 and 2015 (includes corresponding Graph/Chart)
- Table 13: World Recent Past, Current & Future Analysis for
Interventional Cardiology Devices by Product Segment - Coronary Stents,
Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, Vascular
Sealings and Others Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
- Table 14: World 10-Year Perspective for Interventional Cardiology Devices
by Product Segment - Percentage Breakdown of Dollar Sales for Coronary Stents,
Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, Vascular
Sealings and Others Markets for Years 2006, 2009 and 2015 (includes
corresponding Graph/Chart)
III. MARKET
1. THE UNITED STATES
- A. Market Analysis
- Coronary Artery Disease
- Table 15: The Ten Leading Causes of Death in the US (includes
corresponding Graph/Chart)
- Coronary Heart Disease Statistics
- Rising Obesity Levels Increase Number of Interventional Cardiology
Procedures
- Current and Future Analysis
- Market Overview
- Coronary Stents Market
- Table 16: Angioplasty and Stent Procedures Performed in the US:
2006-2011 (In Thousands) (includes corresponding Graph/Chart)
- Table 17: US Coronary Stents Market (2006-2011): Number of Stents Used
in Angioplasty Procedures by Stent Type (in Thousands) (includes
corresponding Graph/Chart)
- The Emergence, Rise, Fall and Re-emergence of Drug Eluting Stents
- The Angioplasty and Stents Debate Continues
- The Role of Pharmacists
- The Huge Potential
- Table 18: US Drug Eluting Stents Market (2009): Market Share Breakdown
of Value Sales by Leading Brands - Cypher, Endeavor, Taxus, Promus and
Xience (includes corresponding Graph/Chart)
- Product Approvals
- Product Launches
- Strategic Corporate Developments
- Select Players
- B. Market Analytics
- Table 19: US Recent Past, Current & Future Analysis for
Interventional Cardiology Devices Annual Sales Figures in US$ Million for
Years 2006 through 2015 (includes corresponding Graph/Chart)
2. JAPAN
- A. Market Analysis
- Current and Future Analysis
- Market Overview
- Coronary Stents - The Leading IC Device Segment
- US Companies Lead Japanese IC Device Market
- Table 20: Japanese Coronary Stents Market (2007): Market Share
Breakdown of Value Sales by Major Players - Johnson & Johnson, Boston
Scientific, Abbott/Guidant, Medtronic and Others (in US$ Million)
(includes corresponding Graph/Chart)
- Table 21: Japanese Bare-Metal Stents Market (2007): Market Share
Breakdown of Value Sales by Major Players - Medtronic, Abbott/Guidant,
Johnson & Johnson, Boston Scientific,and Others (includes
corresponding Graph/Chart)
- Drug-Eluting Stents
- Table 22: Japanese Coronary Drug-Eluting Stents Market (2009): Market
Share Breakdown of Value Sales by Major Player Johnson & Johnson,
Boston Scientific and Medtronic
- Product Approvals
- Product Launches
- Select Players
- B. Market Analytics
- Table 23: Japanese Recent Past, Current & Future Analysis for
Interventional Cardiology Devices Annual Sales Figures in US$ Million for
Years 2006 through 2015 (includes corresponding Graph/Chart)
3. EUROPE
- A. Market Analysis
- Current and Future Analysis
- Market Overview
- The DES Market
- Table 24: European Coronary Stent Market (2007): Market Share
Breakdown of Value Sales by Company - Boston Scientific, Johnson &
Johnson, Medtronic, Abbott and Others (includes corresponding Graph/Chart)
- Table 25: European Coronary Drug-Eluting Stent Market (2007): Market
Share Breakdown of Value Sales by Company - Boston Scientific, Johnson
& Johnson, Medtronic, Abbott and Others (includes corresponding
Graph/Chart)
- Table 26: European Coronary Bare-Metal Stent Market (2007): Market
Share Breakdown of Value Sales by Company - Abbott, Medtronic, Boston
Scientific, Johnson & Johnson, and Others (includes corresponding
Graph/Chart)
- Technology Innovation Drives PCI Devices Market in Western Europe
- Table 27: Western Europe PCI (Percutaneous Coronary Intervention)
Market (2008): Percentage Breakdown of Sales in Value Terms for Boston
Scientific, Cordis, Medtronic, Abbott and Others (includes corresponding
Graph/Chart)
- Table 28: Western Europe Coronary Stent Market (2008) by Stent Type:
Percentage Breakdown of Sales in Value Terms for Drug-Eluting Stents and
Bare Metal Stents
- Table 29: Western Europe Coronary Stent Market (2008) by Company:
Percentage Breakdown of Sales in Value Terms for Boston Scientific,
Cordis, Medtronic, Abbott and Others (includes corresponding Graph/Chart)
- Table 30: Western Europe Angioplasty Balloon Market (2008) by Company:
Percentage Breakdown of Sales in Value Terms for Biotronik, ClearStream,
Invatec and Others (includes corresponding Graph/Chart)
- Table 31: Western Europe Coronary Catheters Market (2008) by Company:
Percentage Breakdown of Sales in Value Terms for Cordis, Boston
Scientific, Medtronic, Abbott, St. Jude Medical and Others (includes
corresponding Graph/Chart)
- Table 32: Western Europe Coronary Guidewires Market (2008) by Company:
Percentage Breakdown of Sales in Value Terms for Cordis, Boston
Scientific, Abbott, Medtronic, St. Jude Medical and Others (includes
corresponding Graph/Chart)
- Table 33: Western Europe Balloon Inflators Market (2008) by Company:
Percentage Breakdown of Sales in Value Terms for Medtronic, Abbott, Merit
Medical, B. Braun and Others (includes corresponding Graph/Chart)
- Table 34: Western Europe Embolic Protection Devices Market (2008) by
Company: Percentage Breakdown of Sales in Value Terms for Boston
Scientific, Medtronic, Abbott, St. Jude Medical and Others (includes
corresponding Graph/Chart)
- Product Approvals
- Product Launches
- Strategic Corporate Developments
- Select Players
- B. Market Analytics
- Table 35: European Recent Past, Current & Future Analysis for
Interventional Cardiology Devices Annual Sales Figures in US$ Million for
Years 2006 through 2015 (includes corresponding Graph/Chart)
4. ASIA-PACIFIC
- A. Market Analysis
- Current and Future Analysis
- Market Overview
- Table 36: Asia-Pacific Drug Eluting Stents Market (2007): Percentage
Breakdown of Value Sales for China, Korea, India, Australia and Others
(includes corresponding Graph/Chart)
- Table 37: Asia-Pacific Drug Eluting Stents Market (2007): Market Share
Breakdown by Leading Players - Microport, Cordis, JW Medical ,Boston
Scientific and Others (includes corresponding Graph/Chart)
- B. Market Analytics
- Table 38: Asia-Pacific Recent Past, Current & Future Analysis for
Interventional Cardiology Devices by Geographic Region - China, India,
Korea, and Rest of Asia-Pacific Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart)
- Table 39: Asia-Pacific 10-Year Perspective for Interventional Cardiology
Devices by Geographic Region - Percentage Breakdown of Dollar Sales for
China, India, Korea, and Rest of Asia-Pacific Markets for Years 2006, 2009,
and 2015 (includes corresponding Graph/Chart)
4a. CHINA
- A. Market Analysis
- Current and Future Analysis
- Market Overview
- Growth Drivers and Restrains
- Healthcare Reforms to Drive Drug-Eluting Stents Growth
- B. Market Analytics
- Table 40: Chinese Recent Past, Current & Future Analysis for
Interventional Cardiology Devices Annual Sales Figures in US$ Million for
Years 2006 through 2015 (includes corresponding Graph/Chart)
4b. INDIA
- A. Market Analysis
- Current and Future Analysis
- Market Overview
- Imported Stents Hold Great Prospects
- Availability of Enhanced DES Ensures Quality Care for Heart Patients
- Product Approval
- Strategic Corporate Developments
- B. Market Analytics
- Table 41: Indian Recent Past, Current & Future Analysis for
Interventional Cardiology Devices Annual Sales Figures in US$ Million for
Years 2006 through 2015 (includes corresponding Graph/Chart)
4c. KOREA
- A. Market Analysis
- Current and Future Analysis
- Market Outlook
- Market Overview
- US Companies Dominate Supply Landscape
- Korean Imports of Interventional Cardiology Devices: Breakdown by Select
Countries of Origin
- Table 42: Korean Interventional Coronary Artery Devices Market
(2007-2009): Number of Procedures for Diagnostic Angiography, and PTCA
Procedures (In Thousands) (includes corresponding Graph/Chart)
- B. Market Analytics
- Table 43: Korean Recent Past, Current & Future Analysis for
Interventional Cardiology Devices by Product Segment - Drug Eluting Stents,
Intravascular Ultrasound, Guiding Catheters, Balloon Catheters, PTCA
Guidewires, and Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2006 through 2015 (includes corresponding
Graph/Chart)
- Table 44: Korean 10-Year Perspective for Interventional Cardiology
Devices by Product Segment - Percentage Breakdown of Dollar Sales for Drug
Eluting Stents, Intravascular Ultrasound, Guiding Catheters, Balloon
Catheters, PTCA Guidewires, and Others Markets for Years 2006, 2009, and
2015 (includes corresponding Graph/Chart)
4d. REST OF ASIA-PACIFIC
- A. Market Analysis
- Current and Future Analysis
- Product Approval
- Select Player
- B. Market Analytics
- Table 45: Rest of Asia-Pacific Recent Past, Current & Future
Analysis for Interventional Cardiology Devices Annual Sales Figures in US$
Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
5. REST OF WORLD
- A. Market Analysis
- Current and Future Analysis
- Product Approvals
- Product Launch
- B. Market Analytics
- Table 46: Rest of World Recent Past, Current & Future Analysis for
Interventional Cardiology Devices Annual Sales Figures in US$ Million for
Years 2006 through 2015 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE
|
 |
